BLISSGVS.BO
BLISSGVS.BO
INE416D01022
BLISS GVS PHARMA LTD.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
68.54B EUR
57.17B EUR
22.8B EUR
17.29B EUR
Enterprise Value
66.91B EUR
57.17B EUR
22.67B EUR
17.29B EUR
Valuation Multiples
Trailing P/E
51.15x
41.98x
17.66x
18.48x
Forward P/E
64.46x
--
--
--
Price to Sales
6.82x
5.69x
2.46x
2.58x
Price to Book
5.72x
--
1.91x
--
EV/Revenue
6.66x
5.69x
2.45x
2.58x
EV/EBITDA
34.81x
23.17x
9.54x
9.5x
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
--
--
--
--
ende